Bentham Science Logo

Track Your Manuscript:


Current Cancer Drug Targets

Volume 20, 11 Issues, 2020
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Contents

Current Cancer Drug Targets, Volume 16 - Number 7



Review Article

nMET, A New Target in Recurrent Cancer

, 16(7): 572 - 578

Yingqiu Xie, Sholpan Istayeva, Zhanlin Chen, Tursonjan Tokay, Zhaxybay Zhumadilov, Denglong Wu, Gonzalo Hortelano and Jinfu Zhang


DOI: 10.2174/1568009616666160105105250




Review Article

Roles of Interferon Regulatory Factors in Chronic Myeloid Leukemia

, 16(7): 594 - 605

Livia Manzella, Elena Tirrò, Maria Stella Pennisi, Michele Massimino, Stefania Stella, Chiara Romano, Silvia Rita Vitale and Paolo Vigneri


DOI: 10.2174/1568009616666160105105857







Editor-in-Chief

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
View Full Editorial Board

COPE Compliant

Journal History

Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.75

Advertisement

New Year Offer 2021Covid Resource Center

Related Journals

Related eBooks

eBooks Catalog